Abstract Aim: Our objective was to systematically assess the prevalence and clinical features of adverse events related to interactions between…
Abstract Genetic influences on acute responses to psychoactive drugs may contribute to individual variability in addiction risk. ABCB1 is a…
Abstract Despite the constant development of new antiepileptic drugs (AEDs), more than 30% of patients develop refractory epilepsy (RE) characterized…
Abstract Cannabidiol (CBD) is currently being investigated as a novel therapeutic for the treatment of CNS disorders like schizophrenia and…